Tinea Capitis
14
2
3
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
21%
3 trials in Phase 3/4
0%
0 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (14)
Efficacy Comparison of Itraconazole Pulse Therapy and Terbinafine Therapy in Treatment of Tinea Capitis in Children.
Comparison Between Continuous and Pulse Itraconazole in Tinea Capitis in Children
Population Pharmacokinetics of Terbinafine in Children With Tinea Capitis
Trichoscopic Predictors of Treatment Response in Tinea Capitis: A Prospective Study
Efficacy and Safety of Topical Amphotericin B Solution in Treatment of Resistant Tinea Capitis in Children 16 Years Old or Less we Follow up Cases Weekly up to 8 Weeks and Notice Improvement of Itching ,Scaling, and Hair Regrowth Then Fungal Culture Done to See if the Solution Working
A Study Of Diflucan In Children With Ringworm Of The Scalp
Effect of L. Rhamnosus Yoba on RTI and Other Health Outcomes Among Children (3-6 Years) in Uganda
Evaluation of Trichoscopy in the Diagnosis of Tinea Capitis
Terbinafine Compared to Griseofulvin in Children With Tinea Capitis
Safety and Efficacy of NAFT900 in Children With Tinea Capitis
Design and Clinical Evaluation of a School Meal With Deworming Properties
The Natural Course of Trichophyton Tonsurans Carriage and Infection: A Molecular and Biochemical Evaluation
Selenium Sulfide, Ketoconazole and Ciclopirox Shampoo as Additional Treatments for Tinea Capitis (Scalp Ringworm)
Terbinafine Compared to Griseofulvin in Children With Tinea Capitis